SECURITIES ALERT: Rosen Law Firm Reminds Aeterna Zentaris,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SECURITIES ALERT: Rosen Law Firm Reminds Aeterna Zentaris, Inc. Investors of Important January 12, 2015 Deadline in Class Action Filed by the Firm -- AEZS

NEW YORK, Dec. 28, 2014 (GLOBE NEWSWIRE) -- Rosen Law Firm reminds purchasers of Aeterna Zentaris, Inc. securities (Nasdaq: AEZS ) between October 18, 2012 and November 6, 2014 of the important January 12, 2015 lead plaintiff deadline in the class action filed by the firm.

To join the AEZS class action, go to the website at http://rosenlegal.com/cases-429.html or call Phillip Kim, Esq. or Jonathan Horne, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or jhorne@rosenlegal.com for information on the class action.   The suit is pending in U.S. District Court for the District of New Jersey.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, the Company misstated information about its New Drug Application ("NDA") with the FDA. On October 18, 2012, the Company announced the Phase III clinical trial results of its drug MACRILEN™ ("MACRILEN"), stating that the results "confirm [MACRILEN's] potential as possibly the first approved oral diagnostic test for [adult growth hormone deficiency]." The Phase III trials were conducted pursuant to a Special Protocol Assessment that was agreed upon with the FDA. The Company then filed an NDA for MACRILEN.  

On November 6, 2014, the Company announced that the FDA would not approve the Company's MACRILEN NDA, as it had received a Complete Response Letter ("CRL"). The Company stated that the FDA's concerns were:

"[T]hat the planned analysis of the Company's pivotal trial did not meet its stated primary efficacy objective as agreed to in the Special Protocol Assessment agreement letter between the Company and the FDA . The CRL further mentioned issues related to the lack of complete and verifiable source data for determining whether patients were accurately diagnosed with AGHD. The FDA concluded that, "in light of the failed primary analysis and data deficiencies noted, the clinical trial does not by itself support the indication."  To address the deficiencies identified above, the CRL states that the Company will need to demonstrate the efficacy of macimorelin as a diagnostic test for growth hormone deficiency in a new, confirmatory clinical study. " That day, the Company's stock price fell from $1.29 to $0.65, damaging investors.

If you wish to join the litigation and recover your losses go to http://rosenlegal.com/cases-429.html or to discuss your rights or interests regarding this class action, please contact, Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com .

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Laurence Rosen, Esq. Phillip Kim, Esq. Jonathan Horne, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 www.rosenlegal.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Chicken Production Rises Amid Meat Market Shifts

Updated Category News Views 187

Protein Markets Scramble: Chicken Production Climbs Here’s a tasty tidbit that might just have investors reeling: the USDA says chicken production will be cruising on the up, whereas beef is taking a bit of a backseat. Yep, the big birds are flying higher, and the cows, well, they're just mooing a little softer. And what's that mean for big players like Tyson...

Continue Reading
LA Auto Show 2026: Thrills, Games, and Cars Galore

Updated Category News Views 53

A Family Day Like No Other at the LA Auto Show Kicking into gear this November, the 2026 Los Angeles Auto Show puts the pedal to the metal for families seeking a full day of fun without breaking the bank. We're talking about 10 solid days where auto-mania meshes with interactive experiences, all nestled in the Los Angeles Convention Center. Whether you're a gearhead or a...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 221

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
AI Alliance Rethinks Health Plan Engagement

Updated Category News Views 139

Building Bridges in Healthcare Ever seen healthcare stuck in its own muck with disconnected gears attempting to move the same machine? Well, that's precisely the mountain healthplans.ai and URAWARRIOR aim to climb down from. Founders Rachel Spilo and Dr. Bershan Shaw are gearing up to shake hands in their no-nonsense, real-world vow to sync member engagement with the...

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 206

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 162

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading
Teamsters Ratify Contract, Averting Waste Strike

Updated Category News Views 117

Big Win for Teamsters Local 350 You ever seen a strike averted by sheer willpower and unity? That’s what's happened here with the workers at South San Francisco Scavenger Company. These folks—drivers, mechanics, sorters, and utility workers—all banded together under the Teamsters Local 350 and showed management what's what by securing a contract they deserve. We're...

Continue Reading
Silvi's Expansion Push: New Terminal in Wilmington

Updated Category News Views 215

Silvi's Latest Bet on the Southeast You know, sometimes you get a gut feeling that a company is rolling out chess moves instead of checkers. That’s what Silvi Materials is up to with their new project in Wilmington. It’s not just some fancy cement terminal—it’s a calculated expansion into the heart of the Southeast construction market. The Port of Wilmington’s...

Continue Reading
Paris Baguette Expands U.S. Presence with New Georgia Café

Updated Category News Views 163

Café Culture Meets Expansion Chase You ever sip a cup of coffee and hear the rustle of opportunity in the steam? That's what's brewing at Paris Baguette with their new opening in Peachtree Corners, Georgia. This isn't just another café setting up shop; it's part of a larger scheme—expanding their sweet slice of the global market pie. Paris Baguette's Georgia Gamble...

Continue Reading

Top 5 Most Recently Viewed Articles

Essential Guidance to Avoid Contractor Fraud After Disasters

Updated Category News Views 249

Essential Guidance for Consumers: Preventing Contractor Fraud In times of devastating natural disasters, such as those caused by wildfires, consumers often find themselves in vulnerable positions. High winds and dry conditions can lead to situations where homes, businesses, and even schools suffer severe damage. It’s in these challenging times that the threat of...

Continue Reading
Stefan Vinberg: A Visionary Leader in Sustainable Real Estate

Updated Category News Views 60

Stefan Vinberg Achieves Dual Recognition at Prestigious Awards Stefan Vinberg, the respected CEO of Insig AB, has recently received outstanding recognition by winning two significant accolades at the Business Worldwide Magazine CEO Awards. These notable honors are the 'Sustainable Real Estate Leadership Award' and 'Growth Strategy CEO of the Year - Sweden'. This...

Continue Reading
SIME Diagnostics Unveils Breakthrough in Neonatal Lung Testing

Updated Category News Views 344

Introduction to AI in Neonatal Medicine SIME Diagnostics is transforming neonatal care with its innovative approach to evaluating lung maturity in preterm infants. This UK-based medical technology company has recently completed a significant clinical study aimed at addressing respiratory challenges faced by late-preterm newborns. The findings promise not only to enhance...

Continue Reading
Baxter Intl's Q4 Results: Key Takeaways and Insights

Updated Category News Views 164

Understanding Baxter Intl's Q4 Earnings The recent earnings report from Baxter Intl (NYSE: BAX) provides crucial insights for investors and analysts alike. In the fourth quarter, the company revealed some significant insights into its financial health and market performance, prompting a closer examination of what this means for shareholders. Earnings Performance Overview...

Continue Reading
Morgan Stanley Sheds Light on UK Investment Trends

Updated Category News Views 99

Insights on UK Investment Intentions From Morgan Stanley Recently, UK assets have captured significant attention, prompting Morgan Stanley (NYSE: MS) to conduct a survey aimed at understanding investors' views, intentions, and positions regarding these assets. This survey highlights the current sentiment surrounding investments in the UK amid uncertain market conditions....

Continue Reading